Publications
364
Citations
16,596
Est. group size
~50
Recurring co-author estimate
Active years
20
Publishing since 2007
Typically publishes in teams of ~13 · 11% small-team papers (≤3 authors) · across 66 venues
- uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome
Circulation Research · 2026
- Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank
Journal of the American Heart Association · 2026
- Restorative Neurostimulation Therapy Compared to Optimal Medical Management: A Randomized Evaluation (RESTORE) for the Treatment of Chronic Mechanical Low Back Pain due to Multifidus Dysfunction
Pain and Therapy · 2025
- Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
JACC CardioOncology · 2025
- ACEi and ARBs as Primary Prevention of Cancer Therapy-Related Cardiomyopathy in Patients Undergoing Chemotherapy with Anthracyclines: A Systematic Review and Meta-Analysis
Cardiology and Therapy · 2025
- Application of International Society for the Study of Women’s Sexual Health consensus algorithm for persistent genital arousal disorder/genito-pelvic dysesthesia to 10 cases and use of epidural spinal injections as long term management
Sexual Medicine · 2025
- Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long‐Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study
Journal of the American Heart Association · 2025
- LIPOPROTEIN(A), SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR, AND CARDIOVASCULAR DISEASE RISK
Journal of the American College of Cardiology · 2025
- Silent Threats Unveiled: The Hidden Pneumothorax in a Chronic Marijuana User
American Journal of Respiratory and Critical Care Medicine · 2025
- Soluble urokinase plasminogen activator receptor (suPAR) for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes
European Heart Journal Open · 2025
- Abstract 4370898: Long-Term Impact of GLP-1 Receptor Agonists on Cardiovascular Outcomes in Patients Treated with Hematopoietic Stem Cell Transplantation: A Propensity-Score Matched Analysis
Circulation · 2025
- Targeting CD11b+ Myeloid Cell Recruitment Therapeutically Treats Lupus Nephritis via Reductions in Soluble Urokinase Plasminogen Activator Receptor (suPAR) and C-C Motif Ligand 2 (CCL2) Levels
Journal of the American Society of Nephrology · 2025
- SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes
JACC CardioOncology · 2024
- Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry
American Heart Journal · 2024
- Benefits of Tadalafil and Sildenafil on Mortality, Cardiovascular Disease, and Dementia
The American Journal of Medicine · 2024
- Journal of the American College of Cardiology×52
- Circulation×32
- Journal of the American Heart Association×16
- European Heart Journal×8
- Journal of the American Society of Nephrology×7
- Anis Ismail
Medicine · University of Michigan
- Rafey Feroze
Medicine · University of Michigan
- Feriel Presswalla
Medicine · University of Michigan
- Tonimarie Catalan
Medicine · University of Michigan
- Chelsea Meloche
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile